Asunaprevir Pharmacokinetics and Safety in Subjects With Impaired Renal Function

被引：0
|
作者：
Garimella, Tushar [1 ]
He, Bing [1 ]
Luo, Wen-Lin [2 ]
Colston, Elizabeth [1 ]
Zhu, Kurt [1 ]
Kandoussi, Hamza [2 ]
Marbury, Thomas C. [3 ]
Alcorn, Harry W. [4 ]
Smith, William B. [5 ]
Eley, Timothy [1 ]
机构：
[1] Bristol Myers Squibb Co, Res & Dev, Hopewell, NJ USA
[2] Bristol Myers Squibb Co, Res & Dev, Lawrenceville, NJ USA
[3] Orlando Clin Res Ctr, Orlando, FL USA
[4] DaVita Clin Res, Minneapolis, MN USA
[5] New Orleans Ctr Clin Res, Knoxville, TN USA
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
463
引用
收藏
页码：430A / 430A
页数：1
相关论文
共 50 条
  • [21] PHARMACOKINETICS OF ASPOXICILLIN IN SUBJECTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION
    GEYER, J
    HOFFLER, D
    KOEPPE, P
    [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1988, 38-2 (11): : 1635 - 1639
  • [22] PHARMACOKINETICS OF AMOXICILLIN IN SUBJECTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION
    ARANCIBIA, A
    DROGUETT, MT
    FUENTES, G
    GONZALEZ, G
    GONZALEZ, C
    THAMBO, S
    PALOMBO, G
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1982, 20 (10) : 447 - 453
  • [23] TEMAFLOXACIN PHARMACOKINETICS IN SUBJECTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION
    GRANNEMAN, GR
    BRAECKMAN, R
    KRAUT, J
    SHUPIEN, S
    CRAFT, JC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) : 2345 - 2351
  • [24] Pharmacokinetics and safety of olodaterol administered with the Respimat Soft Mist inhaler in subjects with impaired hepatic or renal function
    Kunz, Christina
    Luedtke, Doreen
    Unseld, Anna
    Hamilton, Alan
    Halabi, Atef
    Wein, Martina
    Formella, Stephan
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 585 - 595
  • [25] PEGylated Interferon Beta-1a Pharmacokinetics, Pharmacodynamics, and Safety in Subjects with Normal or Impaired Renal Function
    Hu, Xiao
    Seddighzadeh, Ali
    Stecher, Scott
    Miller, Larisa
    Zhu, Ying
    Hung, Serena
    [J]. NEUROLOGY, 2012, 78
  • [26] Pharmacokinetics and Safety of Imeglimin in Japanese Patients With Impaired Renal Function
    Kitamura, Atsushi
    Yumizaki, Takuya
    Kondo, Tomoe
    Sekino, Hisakuni
    Kakuyama, Hiroyoshi
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (07): : 807 - 816
  • [27] Pharmacokinetics and safety of gadobenate dimeglumine (Multihance) in subjects with impaired liver function
    Davies, BE
    Kirchin, MA
    Bensel, K
    Lorusso, V
    Davies, A
    Parker, JR
    Lafrance, ND
    [J]. INVESTIGATIVE RADIOLOGY, 2002, 37 (05) : 299 - 308
  • [28] Safety and pharmacokinetics of DUR-928 in hepatic function impaired subjects
    Shah, Jaymin
    Pozo, Katherine
    Scott, Deborah
    Lin, WeiQi
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S613 - S613
  • [29] Pharmacokinetics and safety of candesartan cilexetil in subjects with normal and impaired liver function
    J. F. W. Hoogkamer
    C. H. Kleinbloesem
    M. Ouwerkerk
    A. Högemann
    A. Nokhodian
    W. Kirch
    E. Weidekamm
    [J]. European Journal of Clinical Pharmacology, 1998, 54 : 341 - 345
  • [30] Pharmacokinetics and safety of candesartan cilexetil in subjects with normal and impaired liver function
    Hoogkamer, JFW
    Kleinbloesem, CH
    Ouwerkerk, M
    Högemann, A
    Nokhodian, A
    Kirch, W
    Weidekamm, E
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (04) : 341 - 345
12345